[1]陆滢屹,陈丽雯,柴 钰,等.强心方联合沙库巴曲缬沙坦对慢性心力衰竭患者中医症候、心室重构及运动耐力的影响[J].陕西中医,2023,(8):1052-1055.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.012]
　LU Yingyi,CHEN Liwen,CHAI Yu,et al.Effects of Qiangxin decoction combined with shakubactril valsartan on TCM symptoms,ventricular remodeling and exercise tolerance in patients with chronic heart failure[J].,2023,(8):1052-1055.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.012]
点击复制

强心方联合沙库巴曲缬沙坦对慢性心力衰竭患者中医症候、心室重构及运动耐力的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年8期
页码:
1052-1055
栏目:
临床研究
出版日期:
2023-08-05

文章信息/Info

Title:
Effects of Qiangxin decoction combined with shakubactril valsartan on TCM symptoms,ventricular remodeling and exercise tolerance in patients with chronic heart failure
作者:
陆滢屹; 陈丽雯; 柴 钰; 翁嘉灏; 邢健东
(上海中医药大学附属市中医医院心病科,上海 200071)
Author(s):
LU Yingyi; CHEN Liwen; CHAI Yu; WENG Jiahao; XING Jiandong
(Department of Cardiology,Municipal Hospital of Traditional Chinese Medicine of Shanghai University of Traditional Chinese Medicine,Shanghai 200071,China)
关键词:
慢性心力衰竭;  强心方;  沙库巴曲缬沙坦;  气虚阳衰;  心肌损伤因子;  运动耐力
Keywords:
Chronic heart failure;  Qiangxin decoction;  Shakubactril valsartan;  Qi deficiency and yang decline;  Myocardial injury factors;  Exercise tolerance
分类号:
R 575.1
DOI:
DOI:10.3969/j.issn.1000-7369.2023.08.012
文献标志码:
A
摘要:
目的:探究强心方联合沙库巴曲缬沙坦对慢性心力衰竭气虚阳衰证患者中医症候、心室重构及运动耐力的影响。方法:将92例慢性心力衰竭气虚阳衰证患者随机分为观察组和对照组,每组46例。两组均进行常规西医规范治疗,对照组给予沙库巴曲缬沙坦,观察组采用强心方联合沙库巴曲缬沙坦。比较两组治疗前、治疗2个月后中医症候积分、心室重构情况[左室舒张末内径(LVEDD)、左室射血分数(LVEF)、左室收缩末内径(LVESD)]、血清心肌损伤因子[血N末端B型钠尿肽前体(NT-proBNP)、心肌钙蛋白(cTnI)、核转录因子(NF-κB)]、运动耐力[6 min步行试验(6MWT)]。结果:治疗后,两组中医症候积分、LVEDD、LVESD、血清NT-proBNP、cTnI、NF-κB水平均显著降低,且观察组低于对照组,差异有统计学意义(均P<0.05); 治疗后,两组LVEF、6MWT水平均显著升高,且观察组高于对照组,差异有统计学意义(均P<0.05)。结论:强心方联合沙库巴曲缬沙坦可有效改善CHF患者临床症状,提高运动耐力,减轻心室重塑和心肌损伤。
Abstract:
Objective:To explore the effects of Qiangxin decoction combined with sacubitril valsartan on TCM syndromes,ventricular remodeling and exercise tolerance in treating chronic heart failure qi deficiency and yang decline syndrome.Methods:92 patients with chronic heart failure qi deficiency and yang decline syndrome were selected as the observation subjects,and they were divided into observation group and control group by stratified randomization method,with 46 cases in each group.Both groups were treated with conventional western medicine standardized treatment,and the control group was given sacubitril valsartan,and the observation group was given Qiangxin decoction combined with sacubitril valsartan.TCM syndromes scores,ventricular remodeling [left ventricular end-diastolic diameter(LVEDD),left ventricular ejection fraction(LVEF),left ventricular end-systolic diameter(LVESD)],serum myocardial injury factors [blood N-terminal pro-B-type natriuretic peptide(NT-proBNP),cardiac troponin(cTnI),nuclear transcription factor(NF-κB)] and exercise tolerance [6 minute walking test(6MWT)] were compared between the two groups before treatment and after 2 months of treatment.Results:After treatment,the TCM syndromes scores,LVEDD,LVESD,serum NT-proBNP,cTnI and NF-κB levels in both groups were significantly decreased,and the above indicators in observation group were lower than those in control group,the difference was statistically significant(all P<0.05).The LVEF and 6MWT in the two groups were significantly increased after treatment,and the indicators in observation group were higher than those in control group,the difference was statistically significant(all P<0.05).Conclusion:Qiangxin decoction combined with shakubactril valsartan can effectively improve clinical symptoms,improve exercise endurance,reduce ventricular remodeling and myocardial injury in patients with chronic heart failure.

参考文献/References:

[1] 吴丝丝,涂雪梅,陈晓莉.慢性心力衰竭患者衰弱研究的进展[J].心血管康复医学杂志,2022,31(6):746-750.
[2] 马 妍,任得志,邱克伟,等.慢性心力衰竭利尿剂抵抗的发病机制与治疗进展[J].世界中医药,2022,17(4):590-594.
[3] 申文文,延欢欢.不同类型慢性心力衰竭患者血清肌钙蛋白T和N末端B型钠尿肽原水平变化及临床意义[J].陕西医学杂志,2021,50(9):1109-1113.
[4] 邓 坤,周 婧,李广兵,等.益气温阳活血利水法治疗慢性心力衰竭疗效观察[J].安徽中医药大学学报,2020,39(4):27-30.
[5] 陈 勇,王 洁,杨 彤,等.心衰病中西医研究进展[J].陕西中医,2022,43(1):134-136.
[6] 周 丽,李春林,雷美霞.益气温阳活血利水方治疗慢性心力衰竭临床疗效及对血清B型利钠肽和心功能的影响[J].河北中医,2021,43(12):1984-1988.
[7] 乔利杰,李 彬,彭广操,等.益气活血方及其拆方治疗冠心病心力衰竭气虚血瘀证的双盲随机对照试验[J].中华中医药杂志,2023,38(2):881-886.
[8] 吴怡茹,胡 木,胡 影,等.利水强心方治疗射血分数降低性心力衰竭的疗效及安全性研究[J].中国临床医生杂志,2023,51(2):236-240.
[9] 中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789.
[10] 冠心病中医临床研究联盟,中国中西医结合学会心血管疾病专业委员会,中华中医药学会心病分会等.慢性心力衰竭中医诊疗专家共识[J].中医杂志,2014,55(14):1258-1260.
[11] 覃松梅,邓艺新,刘 航,等.6 min步行试验和评分量表评估COPD的预后[J].临床与病理杂志,2021,41(10):2395-2399.
[12] 连妍洁,蒋燕君,佟 彤,等.基于数据挖掘探析刘红旭治疗慢性心力衰竭用药规律[J].北京中医药,2022,41(1):82-87.
[13] 王 婷,俞瑞群,吴凤珠,等.严氏温阳化瘀利水方治疗慢性心力衰竭临床研究[J].陕西中医,2022,43(10):1396-1399.
[14] 李佳卓,张鸿婷,邹国良,等.益气温阳、活血利水法治疗慢性心力衰竭的临床观察[J].中医药学报,2021,49(10):81-85.
[15] 王 莉,杨 峰.补中益气汤结合西医常规疗法治疗气虚型慢性心力衰竭[J].国际中医中药杂志,2018,40(11):1016-1019.
[16] 罗远林,徐燕梅,谭志强,等.强心方对慢性心力衰竭大鼠心肌线粒体能量代谢与自噬的影响[J].广州中医药大学学报,2022,39(7):1622-1629.
[17] 高 飞,付 强,包书茵,等.中医药治疗慢性心力衰竭机制的研究进展[J].中医药信息,2022,39(5):85-89.
[18] 陈 鹏,李嘉宁,刘 莉,等.参芪益心方对心力衰竭大鼠心功能及其心肌细胞凋亡率的影响[J].中国中医急症,2022,31(7):1161-1164.
[19] 胡蕊蕊,付 慧,韩晓燕,等.丹参“药对”及制剂对心血管保护的药理作用与临床研究进展[J].中医药学报,2023,51(5):106-110.
[20] 纪 翔,林 谦,徐江林,等.基于网络药理学及分子对接探究党参治疗射血分数保留性心力衰竭的分子机制[J].中西医结合心脑血管病杂志,2023,21(7):1161-1168.
[21] 兰真真,瞿惠燕,戎靖枫,等.基于网络药理学探讨鹿角方治疗慢性心力衰竭的作用机制[J].中西医结合心脑血管病杂志,2022,20(24):4463-4468,4504.
[22] 于武华,钟凌云,叶协滔,等.阴附片、阳附片对慢性心衰大鼠RAAS系统的调控作用[J].中药药理与临床,2020,36(3):144-148.
[23] 曹雅雯,汤岐梅,侯雅竹,等.葶苈子治疗心力衰竭的药理研究进展[J].中西医结合心脑血管病杂志,2019,17(20):3123-3126.
[24] 鲁文静,任 慧,崔小敏,等.猪苓利水渗湿的药效物质、药理作用机制及临床应用研究进展[J].中国药房,2023,34(11):1399-1403.
[25] 王婧琳,付新军,李亚军.“茯苓”之文献考察:名称、来源和功效[J].中药材,2021,44(1):219-223.
[26] 刘海燕,宋毓青,陈永福,等.沙库巴曲缬沙坦对射血分数降低型慢性心力衰竭患者的临床疗效及对B型脑钠肽和C反应蛋白水平的影响[J].中国医药,2022,17(1):15-18.
[27] 刘 哲,刘易婷,王 晶.沙库巴曲缬沙坦联合达格列净治疗2型糖尿病合并心力衰竭临床疗效观察[J].陕西医学杂志,2022,51(3):355-358.
[28] 翁嘉灏,胡晓贞.强心方加减联合西药治疗慢性心力衰竭患者的疗效及对其心功能指标、心肌重塑的影响[J].世界中西医结合杂志,2022,17(12):2475-2480.
[29] 王 晶,马思佳,宁冰冰,等.强心方颗粒剂联合常规治疗对老年冠心病心力衰竭患者的临床疗效[J].老年医学与保健,2022,28(5):1097-1100.
[30] 袁晨越,董耀荣,刘晨萍.强心方治疗心肾阳虚型慢性心力衰竭的临床观察[J].上海中医药大学学报,2021,35(4):12-17.

相似文献/References:

[1]杨自生,金 琪,简立国.参苓养心汤治疗慢性心衰的疗效及对心功能、活动耐力、 NTProBNP、hsCRP的影响*[J].陕西中医,2019,(2):167.
　YANG Zisheng,JIN Qi,JIAN Liguo..The effect of Shenling Yangxin decoction on chronic heart failure and its effect on cardiac function，activity endurance，NTProBNP and hsCRP[J].,2019,(8):167.
[2]孙 哲,杨 默,石宗华.丹参多酚酸盐与丹参酮治疗慢性心力衰竭临床研究[J].陕西中医,2019,(5):591.
　SUN Zhe,YANG Mo,SHI Zonghua..Clinical effect and mechanism of salvianolate and Tanshinone in the treatment of chronic heart failure[J].,2019,(8):591.
[3]向宗兴,拓 文,仇卫峰,等.黄芪保心汤配合西药治疗慢性心力衰竭临床研究*[J].陕西中医,2019,(8):1085.
　XIANG Zongxing,TUO Wen,QIU Weifeng,et al.Clinical value of Huangqi Baoxin decoction combined with western medicine in the treatment of chronic heart failure[J].,2019,(8):1085.
[4]尚加芬.参芪附仙饮联合盐酸曲美他嗪片辨治慢性心力衰竭心肾阳虚证临床研究[J].陕西中医,2020,(1):38.
[5]陈宗伟,沈志涛,郑振国,等.芪苈强心胶囊配合保元汤加减治疗慢性心力衰竭临床研究*[J].陕西中医,2020,(2):191.
　CHEN Zongwei,SHEN Zhitao,ZHENG Zhenguo,et al.Observation on the effect of Qili Qiangxin capsules assist Baoyuan decoction in the treatment of chronic heart failure[J].,2020,(8):191.
[6]凌 望,孙思明,王璐玲,等.温阳益气活血方改善慢性心力衰竭患者生活质量临床研究*[J].陕西中医,2020,(5):621.[doi:DOI:10.3969/j.issn.10007369.2020.05.019]
　LING Wang,SUN Siming,WANG Luling,et al.A Study on the quality of life about Wenyang Yiqi Huoxue therapy in the treatment of chronic heart failure[J].,2020,(8):621.[doi:DOI:10.3969/j.issn.10007369.2020.05.019]
[7]朱 杰,林兆奋△,胡 聃,等.中西医结合治疗慢性心力衰竭研究进展*[J].陕西中医,2020,(9):1342.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.046]
[8]刘 薇,张玉焕,李 争.芪参益气滴丸对老年气虚血瘀型心力衰竭患者心肌保护、炎症状态的影响[J].陕西中医,2021,(1):37.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.008]
　LIU Wei,ZHANG Yuhuan,LI Zheng.Effects of Qishen Yiqi dropping pills on myocardial protection,inflammatory state and serum cell adhesion molecule level in elderly patients with heart failure caused by qi deficiency and blood stasis[J].,2021,(8):37.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.008]
[9]黄光明.理中汤加减治疗慢性心力衰竭及对患者血清BNP、IL-10及NOS水平的影响研究[J].陕西中医,2021,(2):159.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.006]
　HUANG Guangming.Modified Lizhong decoction on clinical symptoms and levels of serum BNP,IL-10 and NOS in patients with chronic heart failure[J].,2021,(8):159.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.006]
[10]胡 芳,谭明娜,谭小娥,等.加味五苓散联合西药治疗慢性心力衰竭疗效及对患者心功能、纤维化指标、炎性因子水平的影响[J].陕西中医,2021,(2):167.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.008]
　HU Fang,TAN Mingna,TAN Xiao'e,et al.Effects of modified Wuling powder combined with western medicine on levels of cardiac function,fibrosis indicators and inflammatory factors in patients with chronic heart failure[J].,2021,(8):167.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.008]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(82104758)
更新日期/Last Update: 2023-08-10